Join expert faculty as they discuss part two of what you need to know about obesity and newer treatment options. This episode touches on guidelines, off-label uses, type 1 diabetes and obesity, drug shortages, weight targets and plateaus, frequency of monitoring, and more!
Jennifer N. Clements, PharmD, BCPS, BCACP, BC-ADM, CDCES, FCCP, FADCES is a Clinical Professor and Director of Pharmacy Education with the University of South Carolina College of Pharmacy at the School of Medicine – Greenville Campus. Dr. Clements earned her Pharm.D. from Campbell University in 2006 and completed a primary care pharmacy practice residency in 2007 at the Ralph H. Johnson VA Medical Center in Charleston, South Carolina. She is a board-certified pharmacotherapy specialist, board-certified ambulatory care pharmacist, certified diabetes care and education specialist, and board certified in advanced diabetes management. Dr. Clements She has authored numerous publications and presentations related to diabetes and obesity pharmacotherapy.
Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP is an endocrine clinical pharmacy specialist and the director of Education and Training in Diabetes Technology at the Cleveland Clinic. Dr. Isaacs serves in leadership roles for several pharmacy and diabetes organizations. She served on the ADA Professional Practice Committee for 2020-2023, the committee that updates the ADA Standards of Care. She is a national board member of the Association of Diabetes Care and Education Specialists. Dr. Isaacs was awarded the Ohio Pharmacists Association Under 40 Award in 2019 and was the 2020 ADCES Diabetes Care and Education Specialist of the Year. In 2022, she was inducted into the Southern Illinois University Edwardsville Hall of Fame for her far-reaching contributions in patient care.
Relevant Financial Relationship Disclosures
The following persons in control of this activity’s content have relevant financial relationships:
All other persons in control of content do not have any relevant financial relationships with an ineligible company. As defined by the Standards of Integrity and Independence in Accredited Continuing Education definition of ineligible company.
